CDKN2A and neoplasm: Interestingly, exome analysis of EACs showed that the majority (about 62%) of these carcinomas emerged following genome doubling and that tumors with genome doubling exhibited different patterns of genomic alterations with more frequent oncogenic amplifications and less frequent inactivation of tumor suppressors, including CDKN2A [28] (Figure 3).